• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 对高级别导管原位癌(HG DCIS)管理的影响,我们是否充分利用了 MRI 的全部范围?

Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?

机构信息

Glenfield Hospital, University Hospitals of Leicester, Groby Road, Leicester LE3 9QP, United Kingdom.

Heartlands Hospitals, Heart of England NHS foundation Trust, Bordesley Green E, Birmingham B9 5SS, United Kingdom.

出版信息

Eur J Radiol. 2017 Oct;95:271-277. doi: 10.1016/j.ejrad.2017.08.027. Epub 2017 Aug 31.

DOI:10.1016/j.ejrad.2017.08.027
PMID:28987679
Abstract

INTRODUCTION

Preoperative assessment of pure Ductal Carcinoma Insitu (DCIS) is essential in the surgical planning. The role of Magnetic resonance imaging (MRI) has long been debated. The impact of MRI on the management of High Grade (HG) DCIS was assessed, whether it accurately captures the true size of this entity in comparison to conventional imaging, and, if MRI use would reduce the number of re-excision surgery.

METHOD

Ninety-one consecutive patients with HG DCIS, who were identified from a prospectively collected data at Kettering General Hospital between April 2011 and December 2015. All patients had preoperative MRI scan in addition to the standard breast imaging. This was compared to a control group of consecutive patients (n=52) which was obtained from a period just before 2011. Impact on surgical planning and number of surgeries for each patient was compared. The size of HG DCIS estimated by MRI was compared to the final histological size. Secondary outcomes included change of initial surgical plan and detection of occult contralateral breast cancer.

RESULTS

MRI group had 91 patients with median age of 63. Seventy percent of which presented through the screening program. The overall sensitivity of MRI to detect HG DCIS was 77% (70/91) with a false negative rate FNR of 23% (21/91). Therefore, 70 patients only were included in the data analysis. The control group included 52 screening patients with comparable baseline characteristics. Re-excision (or completion mastectomy) rates were higher in the control group 26% compared to 8% in the MRI group (P-value 0.012). MRI use correctly converted the initial plan of breast conservation to mastectomy in 9 patients (13%). Five patients had additional ipsilateral malignant features (7%).Occult contra lateral disease, was diagnosed in 2 patients (3%).

CONCLUSION

This study suggests that MRI could be an important tool in reducing the re-excision rates in the surgical management of HG DCIS. Although still controversial, selective MRI imaging can be useful in the preoperative diagnosis and evaluation of HG DCIS. Case by case discussion at MDT is crucial. Wider adaptation of MRI when indicated in the assessment of breast lesions with proper correlation to histology postoperatively is a key in improving our MRI interpretation skills, helping us to exploit the full scope of this useful tool.

摘要

简介

术前评估单纯导管原位癌(DCIS)对于手术计划至关重要。磁共振成像(MRI)的作用一直存在争议。本研究评估了 MRI 对高级别(HG)DCIS 管理的影响,是否能准确地比传统影像学更准确地捕获实体的真实大小,以及 MRI 的使用是否会减少再次切除手术的数量。

方法

从 2011 年 4 月至 2015 年 12 月期间,在凯特林综合医院前瞻性收集的数据中,连续确定了 91 例 HG DCIS 患者。所有患者均接受术前 MRI 扫描和标准乳腺影像学检查。将这组患者与连续患者(n=52)进行对比,后者来自 2011 年之前的一个时期。比较每位患者的手术计划和手术次数的影响。通过 MRI 估计的 HG DCIS 大小与最终组织学大小进行比较。次要结果包括初始手术计划的变化和隐匿性对侧乳腺癌的检测。

结果

MRI 组有 91 例患者,中位年龄为 63 岁。其中 70%是通过筛查计划发现的。MRI 检测 HG DCIS 的总体敏感性为 77%(70/91),假阴性率为 23%(21/91)。因此,只有 70 例患者纳入数据分析。对照组包括 52 例筛查患者,具有可比的基线特征。对照组(26%)的再次切除(或完成乳房切除术)率高于 MRI 组(8%)(P 值=0.012)。MRI 组 9 例(13%)患者的初始保乳手术计划被正确转为乳房切除术。5 例患者同侧有额外的恶性特征(7%)。2 例(3%)患者诊断出隐匿性对侧疾病。

结论

本研究表明,MRI 可能是减少 HG DCIS 手术管理中再次切除率的重要工具。尽管仍存在争议,但选择性 MRI 成像可在 HG DCIS 的术前诊断和评估中发挥作用。多学科团队(MDT)的病例讨论至关重要。在评估具有适当术后组织学相关性的乳腺病变时,在适当的情况下广泛采用 MRI,并提高我们对 MRI 解读技能的认识,这是充分利用这一有用工具的关键。

相似文献

1
Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?MRI 对高级别导管原位癌(HG DCIS)管理的影响,我们是否充分利用了 MRI 的全部范围?
Eur J Radiol. 2017 Oct;95:271-277. doi: 10.1016/j.ejrad.2017.08.027. Epub 2017 Aug 31.
2
Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?乳腺磁共振成像(MRI)是否有助于诊断近期诊断为单纯导管原位癌(DCIS)患者的其他病变部位?
Eur J Radiol. 2017 Nov;96:74-79. doi: 10.1016/j.ejrad.2017.09.014. Epub 2017 Sep 28.
3
Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients.乳腺磁共振成像对导管原位癌术前诊断的附加价值:362例患者的诊断性能
Clin Breast Cancer. 2017 Jun;17(3):e127-e134. doi: 10.1016/j.clbc.2016.12.007. Epub 2016 Dec 29.
4
Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.术前乳腺 MRI 可显著改善经针吸活检诊断为单纯 DCIS 患者的手术治疗效果:来自 MIPA 研究的患者匹配分析。
Eur Radiol. 2024 Jun;34(6):3970-3980. doi: 10.1007/s00330-023-10409-5. Epub 2023 Nov 24.
5
Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.靶向术中放疗用于治疗乳腺导管原位癌
Breast J. 2016 Jan-Feb;22(1):63-74. doi: 10.1111/tbj.12516. Epub 2015 Nov 3.
6
Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).乳腺影像报告和数据系统(BI-RADS®)磁共振成像(MRI)在乳腺导管原位癌(DCIS)检测中的预测价值。
Eur J Radiol. 2016 Oct;85(10):1701-1707. doi: 10.1016/j.ejrad.2016.07.010. Epub 2016 Jul 19.
7
Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.术前乳腺磁共振成像和磁共振引导手术对有和无 DCIS 成分的浸润性乳腺癌患者诊断和手术结果的影响。
Radiology. 2017 Sep;284(3):645-655. doi: 10.1148/radiol.2017161449. Epub 2017 Apr 26.
8
Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.乳腺 MRI 对乳腺癌患者手术决策的疗效:导管原位癌与浸润性导管癌。
BMC Cancer. 2020 Sep 29;20(1):934. doi: 10.1186/s12885-020-07443-7.
9
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).术前乳腺 MRI 对新诊断的导管原位癌的应用:多中心研究中的影像学特征和表现(ECOG-ACRIN E4112 试验)。
Radiology. 2021 Oct;301(1):66-77. doi: 10.1148/radiol.2021204743. Epub 2021 Aug 3.
10
Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.乳腺磁共振成像对适合保乳手术及术中放疗的女性的影响。
Surg Oncol. 2018 Mar;27(1):95-99. doi: 10.1016/j.suronc.2018.01.001. Epub 2018 Jan 8.

引用本文的文献

1
Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.术前乳腺 MRI 可显著改善经针吸活检诊断为单纯 DCIS 患者的手术治疗效果:来自 MIPA 研究的患者匹配分析。
Eur Radiol. 2024 Jun;34(6):3970-3980. doi: 10.1007/s00330-023-10409-5. Epub 2023 Nov 24.
2
Does pre-operative breast MRI have an impact on surgical outcomes in high-grade DCIS?术前乳腺 MRI 是否会影响高级别 DCIS 的手术结果?
Br J Radiol. 2022 Sep 1;95(1138):20220306. doi: 10.1259/bjr.20220306. Epub 2022 Jul 25.
3
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
乳腺磁共振成像后导管原位癌手术偏好与接受情况的相关性:ECOG-ACRIN 癌症研究组(E4112)的辅助研究。
JAMA Netw Open. 2022 May 2;5(5):e2210331. doi: 10.1001/jamanetworkopen.2022.10331.
4
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).术前乳腺磁共振成像在导管原位癌患者中的应用: 欧洲委员会乳腺癌倡议(ECIBC)的系统评价。
Eur Radiol. 2021 Aug;31(8):5880-5893. doi: 10.1007/s00330-021-07873-2. Epub 2021 May 30.
5
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.鉴别低级别导管原位癌(DCIS)与非低级别 DCIS 或升级为浸润性癌的 DCIS:超快速动态对比增强磁共振成像的有效纹理特征。
Breast Cancer. 2021 Sep;28(5):1141-1153. doi: 10.1007/s12282-021-01257-6. Epub 2021 Apr 26.